BioTech Mag Search: Vaccine
Financial Times: How to vaccinate the world
7 days ago - By Green Light Biosciences
GreenLight Biosciences is mentioned in the Financial Times looking at how to vaccinate the world.
GreenLight Biosciences is mentioned in the Financial Times looking at how to vaccinate the world. The company is mentioned in relation to the potential of RNA for other uses in agriculture as well as vaccination programmes. An Extract is below:
One day we could have mRNA-based vaccines for HIV, tuberculosis and cancer, says Ugur Sahin, co-founder of BioNTech and developer of Pfizer's vaccine. RNA solutions could be used in agriculture instead of chemical pesticides, says GreenLight...
Read more ...
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Principal Scientist - Bachem - Vista, CA
Ability to effectively organize, multitask, and work in a fast-paced, deadline driven work environment. Serve as subject matter expert for internal/external...From Bachem...
Clinical and molecular heterogeneity of pineal parenchymal tumors: a...
Abstract Recent genomic studies have shed light on the biology and inter-tumoral heterogeneity underlying pineal parenchymal tumors, in particular pineoblastomas and pineal...
UFGI Publication Round-up: Week of 4/12/21
Virtual special issue of the fifth biennial meeting of the north american society for comparative endocrinology (Sociedad norteamericana de endocrinologĂa comparada; SocietĂ©...
Comparative regulomics supports pervasive selection on gene dosage following...
Whole genome duplication events have played a major role in eukaryotic genome evolution, but the consequence of these extreme events in adaptive genome evolution is still not...
PD-L1 lncRNA splice isoform promotes lung adenocarcinoma progression via...
Although using a blockade of programmed death-ligand 1 to enhance T cell immune responses shows great promise in tumor immunotherapy, the immune-checkpoint inhibition strategy...
Unlocking richer intracellular recordings
A forward-thinking group of researchers has identified a flexible, low-cost, and biocompatible platform for enabling richer intracellular recordings.
U.S. Power Sector is Halfway to Zero Carbon Emissions
By Kiran Julin and Bentham Paulos Concerns about climate change are driving a growing number of states, utilities, and corporations to set the goal of zeroing out power-sector...
Aging signatures across diverse tissue cells in mice
Researchers have identified molecular signatures of the aging process in mice.
Amoeba biology reveals potential treatment target for lung disease
In a series of experiments that began with amoebas - single-celled organisms that extend podlike appendages to move around - scientists say they have identified a genetic...
Molecular assembly line to design, test drug compounds streamlined
Researchers have fine-tuned the molecular assembly line that creates antibiotics via engineered biosynthesis.